China Digest: Qiming leads $37m Series B in Insilico Medicine; IceKredit raises $47m

Insilico Medicine, an AI-technology drug discovery firm, has raised $37 million in its Series B funding while risk management platform IceKredit secures $47 million in pre-Series C round.